A prototype of Ducati's forthcoming Desmo450MX race bike drew crowds at Anaheim's Supercross races at the start of 2025, and ...
Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.
Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback